European Medicines Agency Evaluation of Medicines for Human Use London, August 2009 EMEA V1.0

First Page		Document Content
Date: 2016-08-19 03:14:52 Clinical research Clinical data management Pharmaceutical industry Electronic common technical document Pharmaceuticals policy Marketing authorization Probability distribution Validation		European Medicines Agency Evaluation of Medicines for Human Use London, August 2009 EMEA V1.0 Add to Reading List Source URL: esubmission.ema.europa.eu Download Document from Source Website File Size: 504,01 KB Share Document on Facebook

	TIGes vet Q&A-update - Sept 2013 DocID: 1rsZK - View Document
	BPGWorksharingEMA-CMDv DocID: 1rr9m - View Document
	CMDh meeting with representative of Interested Parties 19 May 2015  Type IA variation label implementation guidance. DocID: 1rqES - View Document
	Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions <> "Error"Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions \ MERGEFORMAT Annex VI: Imple DocID: 1rqtS - View Document
	Quasi Drug Rules in Japan December 2011 Quasi-drugs are a unique product classification in Japan. A quasi-drug is defined in Japan as products that have minimal to moderate pharmacologic activity but are restricted in us DocID: 1rpxR - View Document